Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)May 31, 2025 | (FY)Feb 28, 2025 | (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | (FY)Feb 28, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 16.09%5.54B | 3.55%23.92B | 28.83%6.81B | -30.56%4.78B | 8.08%23.1B | 5.72B | -21.64%5.22B | -4.42%5.29B | 46.56%6.88B | 16.02%21.38B |
| Cost of revenue | 10.08%4.24B | 0.37%19.21B | 21.25%5.41B | -32.44%3.86B | 6.55%19.14B | 4.64B | -23.07%4.33B | -3.24%4.47B | 44.04%5.71B | 16.57%17.96B |
| Gross profit | 41.29%1.3B | 18.91%4.71B | 70.10%1.39B | -21.37%920.38M | 16.15%3.96B | 1.08B | -13.84%891.16M | -10.33%819.86M | 60.17%1.17B | 13.17%3.41B |
| Operating expense | 21.82%703.54M | 15.87%2.69B | 21.44%628.53M | 11.78%577.54M | 6.71%2.32B | 718.81M | 8.38%571.38M | 5.29%517.56M | -0.78%516.68M | 3.57%2.18B |
| Operating profit | 74.10%596.87M | 23.22%2.02B | 153.42%766.08M | -47.57%342.84M | 32.81%1.64B | 361.94M | -36.95%319.79M | -28.50%302.3M | 211.25%653.85M | 35.31%1.23B |
| Net non-operating interest income (expenses) | -48.78%-305K | 121.46%391K | 124.31%35K | -10.22%-205K | -130.34%-1.82M | -1.32M | 3.43%-169K | -27.43%-144K | 55.40%-186K | 93.91%-791K |
| Non-operating interest income | 171.05%103K | 305.78%1.19M | 216.67%209K | -37.70%38K | -28.81%294K | --120K | -37.33%47K | -25.84%66K | -30.68%61K | -94.45%413K |
| Non-operating interest expense | 67.90%408K | -62.10%802K | -17.14%174K | -1.62%243K | 75.75%2.12M | --1.44M | -13.60%216K | 3.96%210K | -51.09%247K | -94.11%1.2M |
| Net investment income | 24.24%2.46M | 65.00%1.98M | 0 | 1.02M | -99.30%1.2M | |||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 23.13M | 0 | ||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 0 | 2,076.07%12.96M | 15,050.48%15.91M | -106.03%-28K | -656K | -16.97M | 3,562.33%15.75M | -79.13%105K | -56.27%464K | 0 |
| Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | ---- | ---15.18M | ---11K | ---- | ---- | ---- | --0 |
| Less:Other special charges | ---- | -2,076.07%-12.96M | -15,050.48%-15.91M | 106.03%28K | --656K | --1.8M | -34.19%-577K | 79.13%-105K | 56.27%-464K | ---- |
| Other non-operating income (expenses) | -63.57%749K | -71.81%5.94M | -93.24%1.08M | 45.30%2.06M | 0.27%21.08M | 17.91M | -2,474.67%-14.25M | 5.78%16M | 389.62%1.42M | 115.38%21.02M |
| Income before tax | 73.30%597.31M | 24.40%2.06B | 145.69%784.31M | -47.42%344.66M | 32.18%1.66B | 361.55M | -36.59%322.14M | -27.27%319.23M | 210.68%655.54M | -92.86%1.25B |
| Income tax | 79.49%221.47M | 17.85%646.85M | 123.01%219.17M | -44.09%123.38M | 36.79%548.88M | 131.5M | -30.15%98.43M | -19.67%98.28M | 114.47%220.68M | -94.17%401.24M |
| Net income | 69.85%375.84M | 27.64%1.42B | 155.78%565.14M | -49.12%221.28M | 30.01%1.11B | 230.05M | -39.06%223.71M | -30.20%220.95M | 302.24%434.87M | -92.01%853.43M |
| Net income continuous operations | 69.85%375.84M | 27.64%1.42B | 155.78%565.14M | -49.12%221.28M | 30.01%1.11B | --230.05M | -39.06%223.71M | -30.20%220.95M | 302.24%434.87M | -92.01%853.43M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Net income attributable to the company | 69.85%375.84M | 27.64%1.42B | 155.78%565.14M | -49.12%221.28M | 30.01%1.11B | 230.05M | -39.06%223.71M | -30.20%220.95M | 302.24%434.87M | -92.01%853.43M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 69.85%375.84M | 27.64%1.42B | 155.78%565.14M | -49.12%221.28M | 30.01%1.11B | 230.05M | -39.06%223.71M | -30.20%220.95M | 302.24%434.87M | -92.01%853.43M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 70.33%110.95 | 29.48%417.62 | 161.31%166.53 | -48.07%65.14 | 30.25%322.54 | 67.83 | -38.33%65.55 | -30.78%63.73 | 294.43%125.43 | -92.51%247.64 |
| Diluted earnings per share | 70.33%110.95 | 29.48%417.62 | 161.31%166.53 | -48.07%65.14 | 30.25%322.54 | 67.7222 | -38.33%65.55 | -30.78%63.7297 | 294.43%125.43 | -92.51%247.64 |
| Dividend per share | 0 | 28.57%135 | 0 | 0 | 31.25%105 | 105 | 0 | 0 | 0 | 0.00%80 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |